• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Best practices for selling rare disease drugs

anonymous

Guest
For sales reps who are responsible for targeting hematologists and heme-oncs for selling a rare-disease drug, how many individual physicians are typically visited in a day
 




For sales reps who are responsible for targeting hematologists and heme-oncs for selling a rare-disease drug, how many individual physicians are typically visited in a day

So you basically want to know what Alexion reps do all day?

Its a hard fucking job. Huge territories, shitty access, and a prohibitively expensive drug that may or may not work